JPRN-UMIN000043235
Recruiting
N/A
An exploratoly study to evaluate biomarkers in cell free DNA of "Sequential therapy from afatinib to osimertinib for EGFR mutant non small cell lung cancer: a multicenter prospective observational study (Gio Tag Japan)". - Biomarker study in cell free DNA of Gio-Tag Japan.
HANSHIN Oncology Group0 sites93 target enrollmentFebruary 3, 2021
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- non-small cell lung cancer(EGFR mutation positive)
- Sponsor
- HANSHIN Oncology Group
- Enrollment
- 93
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
The exploratory study to evaluate biomarkers in prospective multicenter observational study of atezolizumab combination therapy in patients with unresectable, advanced and recurrent non-small cell lung cancer or extensive disease small cell lung cancer (J-TAIL-2)on-small cell lung cancer or extensive disease small cell lung cancerJPRN-UMIN000043663CHUGAI PHARMACEUTICAL CO., LTD.450
Recruiting
N/A
An exploratory prospective study of the biomarkers of the immune-related adverse events (irAE) and the mechanisms of irAE in solid cancer patients treated with Pembrolizumab.solid cancerJPRN-UMIN000028474Department of Internal Medicine, Division of Medical Oncology, Showa University School of Medicine.30
Completed
N/A
Exploratory study to investigate biomarkers associated with pathogenesis of infantile hemangioma.Infantile hemangiomaJPRN-UMIN000038574Wakayama Medical University45
Not Yet Recruiting
N/A
Exploratory research of biomarkers for investigational drugs using tear fluid samplesJPRN-UMIN000049186Santen Pharmaceutical Co. Ltd.29
Recruiting
N/A
A biomarker assessment study to investigate the influence of high-frequency chest wall oscillations on the clearance of cerebrospinal fluid biomarkersNL-OMON51372Centre for Human Drug Research34